Status: Recruiting
Lumason® Infusion vs. Bolus Administrations
A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).
Participants needed: 106
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Bracco Diagnostics, IncUpdated: Mar 5, 2026Locations: 6
Eligibility criteria
Are at least 18-years old; [+2]
Patient has severe congestive heart failure (class IV according to the classific... [+9]